Rockefeller Financial Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Rockefeller Financial Services's NVS Position: Q4 2017 in Review
Rockefeller Financial Services reduced its Novartis (NVS) stake by 4.8% in Q4 2017, selling an estimated $4.24M and leaving 1,123,055 shares worth $84.5M. The position accounts for 1.33% of the portfolio, ranked #27.
Rockefeller Financial Services first reported a position in NVS in Q2 2013 and has held it in 19 quarters since. The position peaked at $113M in Q2 2015. 1,006 funds tracked by Wall St. Rank hold NVS as of Q4 2017.
- Rockefeller Financial Services held 1,123,055 shares of Novartis worth $84.5M as of Q4 2017.
- Rockefeller Financial Services sold 56,162 Novartis shares in Q4 2017, an estimated $4.24M.
- Novartis made up 1.33% of Rockefeller Financial Services's portfolio in Q4 2017, its #27 holding.
- Rockefeller Financial Services first reported a position in Novartis in Q2 2013 and has held it in 19 quarters since.
- Rockefeller Financial Services's Novartis position peaked at $113M in Q2 2015.
- 1,006 funds tracked by Wall St. Rank held Novartis as of Q4 2017.
Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.